BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12891555)

  • 1. Transduction of the liver with activated Akt normalizes portal pressure in cirrhotic rats.
    Morales-Ruiz M; Cejudo-Martín P; Fernández-Varo G; Tugues S; Ros J; Angeli P; Rivera F; Arroyo V; Rodés J; Sessa WC; Jiménez W
    Gastroenterology; 2003 Aug; 125(2):522-31. PubMed ID: 12891555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Akt gene therapy for cirrhotic rats with portal hypertension].
    Huang FZ; Deng G; Liu XY; Luo CQ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):31-7. PubMed ID: 18245901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the nitric oxide-cyclic guanosine monophosphate pathway in experimental liver cirrhosis suggests phosphodiesterase-5 as potential target to treat portal hypertension.
    Schaffner D; Lazaro A; Deibert P; Hasselblatt P; Stoll P; Fauth L; Baumstark MW; Merfort I; Schmitt-Graeff A; Kreisel W
    World J Gastroenterol; 2018 Oct; 24(38):4356-4368. PubMed ID: 30344420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amelioration of carbon tetrachloride-induced cirrhosis and portal hypertension in rat using adenoviral gene transfer of Akt.
    Deng G; Huang XJ; Luo HW; Huang FZ; Liu XY; Wang YH
    World J Gastroenterol; 2013; 19(43):7778-87. PubMed ID: 24431897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of extrahepatic vascular Akt improves systemic hemodynamics and sodium excretion in cirrhotic rats.
    Fernández-Varo G; Melgar-Lesmes P; Casals G; Pauta M; Arroyo V; Morales-Ruiz M; Ros J; Jiménez W
    J Hepatol; 2010 Dec; 53(6):1041-8. PubMed ID: 20800923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension.
    Yu Q; Shao R; Qian HS; George SE; Rockey DC
    J Clin Invest; 2000 Mar; 105(6):741-8. PubMed ID: 10727442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension.
    Liu S; Premont RT; Kontos CD; Zhu S; Rockey DC
    Nat Med; 2005 Sep; 11(9):952-8. PubMed ID: 16142243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of portal hypertension and hepatic blood flow in cirrhotic rats by oestrogen.
    Sakamoto M; Ueno T; Nakamura T; Sakata R; Hasimoto O; Torimura T; Sata M
    Eur J Clin Invest; 2005 Mar; 35(3):220-5. PubMed ID: 15733078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of endothelial progenitor cells ameliorates vascular dysfunction and portal hypertension in carbon tetrachloride-induced rat liver cirrhotic model.
    Sakamoto M; Nakamura T; Torimura T; Iwamoto H; Masuda H; Koga H; Abe M; Hashimoto O; Ueno T; Sata M
    J Gastroenterol Hepatol; 2013 Jan; 28(1):168-78. PubMed ID: 22849788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats.
    Thabut D; Tazi KA; Bonnefont-Rousselot D; Aller M; Farges O; Guimont MC; Tellier Z; Guichard C; Ogier-Denis E; Poynard T; Moreau R; Lebrec D
    Hepatology; 2007 Dec; 46(6):1893-906. PubMed ID: 17918268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis.
    Anegawa G; Kawanaka H; Yoshida D; Konishi K; Yamaguchi S; Kinjo N; Taketomi A; Hashizume M; Shimokawa H; Maehara Y
    Hepatology; 2008 Mar; 47(3):966-77. PubMed ID: 18167063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension.
    Iwakiri Y; Tsai MH; McCabe TJ; Gratton JP; Fulton D; Groszmann RJ; Sessa WC
    Am J Physiol Heart Circ Physiol; 2002 Jun; 282(6):H2084-90. PubMed ID: 12003815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin lowers portal pressure in cirrhotic rats by inhibition of RhoA/Rho-kinase and activation of endothelial nitric oxide synthase.
    Trebicka J; Hennenberg M; Laleman W; Shelest N; Biecker E; Schepke M; Nevens F; Sauerbruch T; Heller J
    Hepatology; 2007 Jul; 46(1):242-53. PubMed ID: 17596891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats.
    Van de Casteele M; Omasta A; Janssens S; Roskams T; Desmet V; Nevens F; Fevery J
    Gut; 2002 Sep; 51(3):440-5. PubMed ID: 12171971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
    García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
    J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenic hemodynamics and decreased endothelial nitric oxide synthase in the spleen of rats with liver cirrhosis.
    Yamaguchi S; Kawanaka H; Yoshida D; Maehara Y; Hashizume M
    Life Sci; 2007 May; 80(22):2036-44. PubMed ID: 17481668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension.
    Rockey DC; Chung JJ
    Gastroenterology; 1998 Feb; 114(2):344-51. PubMed ID: 9453496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of estrogen receptor β selective agonist in ameliorating portal hypertension in rats with CCl4-induced liver cirrhosis.
    Zhang CG; Zhang B; Deng WS; Duan M; Chen W; Wu ZY
    World J Gastroenterol; 2016 May; 22(18):4484-500. PubMed ID: 27182159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.